| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Schepens Eye Research Institute, Harvard Medical School, Boston, MA 02114
CD4+ T cells of the Th1 type play a central role in acute rejection of solid tissue grafts, including orthotopic corneal allografts. Th1 cells, which mediate delayed hypersensitivity, are the polar opposites of CD4+ Th2 cells, and the latter cells cross-regulate Th1 cells through the unique pattern of cytokines they secrete. As such, Th2 cells may have a useful role to play in preventing rejection of corneal allografts. To test this possibility, the immune systems of adult mice were biased toward Th2 responses by immunization with keyhole limpet hemocyanin plus IFA. When immunized subsequently with either OVA or allogeneic corneal tissue, these mice acquired Ag-specific primed T cells of the Th2 type. More important, allogeneic corneas grafted into neovascularized eyes of Th2-biased mice experienced significantly enhanced survival. To demonstrate that enhanced survival was promoted by donor-specific Th2 cells, lymphoid cells from keyhole limpet hemocyanin-immune mice bearing healthy corneal allografts suppressed orthotopic corneal allograft rejection when adoptively transferred into naive, syngeneic recipients. We conclude that acceptance of corneal allografts in neovascularized mouse eyes can be significantly enhanced by biasing the recipient immune system toward Th2 responses.
This article has been cited by other articles:
|
|
 |
|
  J. Yamada, J. Hamuro, A. Fukushima, T. Ohteki, K. Terai, Y. Iwakura, H. Yagita, and S. Kinoshita MHC-Matched Corneal Allograft Rejection in an IFN-{gamma}/IL-17-Independent Manner in C57BL/6 Mice Invest. Ophthalmol. Vis. Sci., May 1, 2009; 50(5): 2139 - 2146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. H. Flynn, M. Ohbayashi, Y. Ikeda, S. J. Ono, and D. F. Larkin Effect of Allergic Conjunctival Inflammation on the Allogeneic Response to Donor Cornea Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4044 - 4049. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Beauregard, C. Stevens, E. Mayhew, and J. Y. Niederkorn Cutting Edge: Atopy Promotes Th2 Responses to Alloantigens and Increases the Incidence and Tempo of Corneal Allograft Rejection J. Immunol., June 1, 2005; 174(11): 6577 - 6581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Hargrave, C. Hay, J. Mellon, E. Mayhew, and J. Y. Niederkorn Fate of MHC-Matched Corneal Allografts in Th1-Deficient Hosts Invest. Ophthalmol. Vis. Sci., April 1, 2004; 45(4): 1188 - 1193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Yamada, K. Maruyama, Y. Sano, S. Kinoshita, Y. Murata, and J. Hamuro Promotion of Corneal Allograft Survival by the Induction of Oxidative Macrophages Invest. Ophthalmol. Vis. Sci., February 1, 2004; 45(2): 448 - 454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Maruyama, J. Yamada, Y. Sano, and S. Kinoshita Th2-Biased Immune System Promotion of Allogeneic Corneal Epithelial Cell Survival after Orthotopic Limbal Transplantation Invest. Ophthalmol. Vis. Sci., November 1, 2003; 44(11): 4736 - 4741. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Qian, F. Boisgerault, G. Benichou, and M. R. Dana Blockade of CD40-CD154 Costimulatory Pathway Promotes Survival of Allogeneic Corneal Transplants Invest. Ophthalmol. Vis. Sci., April 1, 2001; 42(5): 987 - 994. [Abstract] [Full Text]
|
|
|
|
 |
|
 Y. Qian, I. Dekaris, S. Yamagami, and M. R. Dana Topical Soluble Tumor Necrosis Factor Receptor Type I Suppresses Ocular Chemokine Gene Expression and Rejection of Allogeneic Corneal Transplants Arch Ophthalmol, December 1, 2000; 118(12): 1666 - 1671. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
